SEC Form 4 · accession 0001209191-16-132725
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul M Silva
Officer — SVP & Corp Controller
Period of report
Jul 12, 2016
Accepted (ET)
Jul 14, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $90.29 | Jul 12, 2016 | A | 13,750 | A | — | Jul 11, 2026 | Common Stock | 13,750 | 13,750 | D |
Explanation of responses
- F1The option vests in 16 quarterly installments from 07/12/2016.